Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Conditions
Brief summary
This study is conducted in Japan. The aim of this study is to collect safety and efficacy data when using insulin aspart in children with diabetes under normal clinical practice conditions.
Interventions
DRUGinsulin aspart
Prescribed by the physicians as a result of normal clinical practice
Sponsors
Novo Nordisk A/S
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
No minimum to 15 Years
Healthy volunteers
No
Inclusion criteria
* Subjects with diabetes requiring insulin therapy
Exclusion criteria
* Subjects who had treatment history of insulin aspart
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response rate assessed by the investigator: Ability or failure to achieve expected glycaemic control | Year 1 |
| HbA1c (glycosylated haemoglobin) | Year 1 |
Secondary
| Measure | Time frame |
|---|---|
| Hypoglycaemic events | Year 1 |
| Adverse Events | Year 1 |
Countries
Japan
Outcome results
None listed